NDC 0069-0504 – Bosulif
Bosutinib Monohydrate 50 mg/1 · Capsule · Oral
Product NDC0069-0504
Product details
- Brand name
- Bosulif
- Generic name
- Bosutinib
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- NDA · NDA217729
- Marketed since
- January 2, 2024
- Listing expires
- December 31, 2027
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Bosutinib Monohydrate 50 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0069-0504-30 | 30 CAPSULE in 1 BOTTLE (0069-0504-30) | Jan 2, 2024 |
Other Bosulif products
- 0069-1014 Bosutinib Monohydrate 100 mg/1 · Capsule · Pfizer Laboratories Div Pfizer Inc
- 0069-0135 Bosutinib Monohydrate 100 mg/1 · Tablet, Film Coated · Pfizer Laboratories Div Pfizer Inc
- 0069-0136 Bosutinib Monohydrate 500 mg/1 · Tablet, Film Coated · Pfizer Laboratories Div Pfizer Inc
- 0069-0193 Bosutinib Monohydrate 400 mg/1 · Tablet, Film Coated · Pfizer Laboratories Div Pfizer Inc
- 63539-193 Bosutinib Monohydrate 400 mg/1 · Tablet, Film Coated · U.S. Pharmaceuticals